On October 15, 2020, Imexpharm was proudly honored as one of the Top 50 Best Vietnamese Listed Companies at the 2020 Business Forum themed 'Navigating Through Turbulence,' organized by Forbes magazine. The event attracted significant attention from investors, entrepreneurs, and economic experts across Vietnam.
Forbes acknowledged that the global COVID-19 pandemic presented unique challenges for publishing this year’s list. However, beyond assessing 2019 financial performance, the rankings also prioritized criteria such as sustainable development, domestic market potential, and resilience. These factors highlight a company’s capacity to recover and thrive once the pandemic is brought under control, making the list a significant benchmark despite the widespread economic disruptions.
Being recognized for the first time as one of Top 50 Best Vietnamese Listed Companies is a well-deserved reward for the collective efforts of the entire Imexpharm team, who have consistently pursued policies focused on quality investment, sustainable development, improved corporate governance, and active community contributions over many years.
The pharmaceutical industry is regarded as a defensive sector, particularly during times of health crises, and has attracted attention from investors and financial experts. Consequently, several pharmaceutical companies were included in this year’s Forbes list. However, Imexpharm’s impressive business results and effective strategies stand out. Amid the ongoing challenges of the pandemic, Imexpharm has managed to maintain continuous production and business operations, uphold high profit margins, and navigate a turbulent market effectively, no small feat during these uncertain times.